Arquivos de Neuro-Psiquiatria (Jun 2015)

Neurofibromatosis: part 2 – clinical management

  • Pollyanna Barros Batista,
  • Eny Maria Goloni Bertollo,
  • Danielle de Souza Costa,
  • Lucas Eliam,
  • Karin Soares Gonçalves Cunha,
  • José Renan Cunha-Melo,
  • Luiz Guilherme Darrigo Junior,
  • Mauro Geller,
  • Ingrid Faria Gianordoli-Nascimento,
  • Luciana Gonçalves Madeira,
  • Hérika Martins Mendes,
  • Débora Marques de Miranda,
  • Nikolas Andre Mata-Machado,
  • Eric Grossi Morato,
  • Érika Cristina Pavarino,
  • Luciana Baptista Pereira,
  • Nilton Alves de Rezende,
  • Luíza de Oliveira Rodrigues,
  • Jorge Bezerra Cavalcanti Sette,
  • Carla Menezes da Silva,
  • Juliana Ferreira de Souza,
  • Márcio Leandro Ribeiro de Souza,
  • Aline Stangherlin Martins,
  • Eugênia Ribeiro Valadares,
  • Paula Vieira Teixeira Vidigal,
  • Vanessa Waisberg,
  • Yehuda Waisberg,
  • Luiz Oswaldo Carneiro Rodrigues

DOI
https://doi.org/10.1590/0004-282X20150042
Journal volume & issue
Vol. 73, no. 6
pp. 531 – 543

Abstract

Read online

Part 1 of this guideline addressed the differential diagnosis of the neurofibromatoses (NF): neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2) and schwannomatosis (SCH). NF shares some features such as the genetic origin of the neural tumors and cutaneous manifestations, and affects nearly 80 thousand Brazilians. Increasing scientific knowledge on NF has allowed better clinical management and reduced rate of complications and morbidity, resulting in higher quality of life for NF patients. Most medical doctors are able to perform NF diagnosis, but the wide range of clinical manifestations and the inability to predict the onset or severity of new features, consequences, or complications make NF management a real clinical challenge, requiring the support of different specialists for proper treatment and genetic counseling, especially in NF2 and SCH. The present text suggests guidelines for the clinical management of NF, with emphasis on NF1.

Keywords